{"schema_version":"secwatch.filing_event.v1","accession":"0001140859-23-000113","form_type":"8-K","ticker":"COR","cik":"0001140859","company_name":"Cencora, Inc.","filed_at":"2023-08-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.233751+00:00","generated_at":"2026-06-12T11:37:43.529834+00:00","sec_items":["2.02","7.01","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"AmerisourceBergen Q3 revenue $66.9B, EPS beat; raises FY guidance; to become Cencora","bullets":["Revenue $66.9B (+11.5% YoY); GAAP EPS $2.35 vs $1.92; adjusted EPS $2.92 vs $2.62.","Adjusted EPS guidance raised to $11.85-$11.95 from $11.70-$11.90 for fiscal 2023.","Company to rename to Cencora and trade under ticker 'COR' on NYSE effective Aug 30, 2023.","CEO cited strong performance and strategic investment in OneOncology during quarter."],"urls":{"canonical":"https://secwatch.observer/filing/0001140859-23-000113","json":"https://secwatch.observer/filing/0001140859-23-000113.json","markdown":"https://secwatch.observer/filing/0001140859-23-000113.md","text":"https://secwatch.observer/filing/0001140859-23-000113.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1140859/000114085923000113/0001140859-23-000113-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1140859/000114085923000113/abc-20230802.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-12T11:37:43.529834+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"a9d3af5a4baa44e25eb7416e9d91392e2e6505fd","claim":"Cencora, Inc. reported fiscal year 2023 third quarter ended June 30, 2023 results: revenue $66.9B, net income $480M, EPS $2.35. Guidance raised.","evidence_excerpt":"Third Quarter Fiscal Year 2023 Summary Results GAAP Adjusted (Non-GAAP) Revenue $66.9B $66.9B Gross Profit $2.3B $2.2B Operating Expenses $1.6B $1.4B Operating Income $670M $822M Interest Expense, Net $58M $58M Effective Tax Rate 21.3% 21.5% Net Income Attributable to AmerisourceBergen Corporation $480M $596M Diluted Earnings Per Share $2.35 $2.92","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1140859/000114085923000113/0001140859-23-000113-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"fiscal year 2023 third quarter ended June 30, 2023"},{"label":"Revenue","value":"$66.9B"},{"label":"Net income","value":"$480M"},{"label":"EPS","value":"$2.35"},{"label":"Guidance","value":"raised"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}